In patients with chronic heart failure after successfully re-vascularized myocardial infarction, CHIP was associated with reduced long-term survival and higher re-hospitalization rates due to heart failure independent from the baseline severity [59]. This evidence concerns the gene STUB1 and myocardial infarction.